Gene And Cell Therapy Products Community

Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy - The AAPS Journal SpringerLink remove preview Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy - The AAPS Journal The number of approved or investigational late phase viral vector gene therapies (GTx) has been rapidly growing. The adeno-associated virus vector (AAV) technology continues to be the most used GTx platform of choice. View this on SpringerLink >

To view the full article through your AAPS membership:

Go to https://www.aaps.org/education-and-research/journals/the-aaps-journal. Click or tap if you trust this link." rel="noopener">https://www.aaps.org/education-and-research/journals/the-aaps-journal 

Enter your AAPS credentials

Click "Member Access to Journals"

Click on the The AAPS Journal cover.

Copy and paste the url into the "Search" box, and click search

The full article should appear.

Follow The AAPS Journal via Twitter https://twitter.com/theaapsjournal?lang=en, and

Linkedin,  https://www.linkedin.com/in/the-aaps-journal-07a6b719b

------------------------------
Ho-Leung Fung Ph.D., FAAPS
Editor-in-Chief
University at Buffalo
Sarasota FL
[email protected]

Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------